Press release content from PR Newswire. The AP news staff was not involved in its creation.
LabConnect Announces Major Clinical Trial Kit Facility Expansion
March 16, 2021 GMT
(PRNewsfoto/LabConnect)
JOHNSON CITY, Tenn., March 16, 2021 /PRNewswire/ LabConnect, a leading global provider of central laboratory and support services for the biopharmaceutical industry, today announced a major expansion of its Johnson City facility. In response to unprecedented demand for LabConnect’s services for cell and gene therapies, immuno-oncology, and other advanced therapeutics, LabConnect has finalized plans to add 20,000 square feet, which will enable a tripling of kit building capacity with other planned operational improvements.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Despite Massive Rise in Drone Incidents, Security Specialists See Traditional Countermeasures as Inadequate, according to IDGA and D-Fend Survey
March 16, 2021 GMT
D Fend Solutions Logo
RA’ANANA, Israel and MCLEAN, VA, March 16, 2021 /PRNewswire/ D-Fend Solutions – the leader in counter-drone, radio frequency-based takeover technology – and the Institute for Defense and Government Advancement (IDGA) – a non-partisan think tank dedicated to the ongoing development and promotion of the Department of Defense, armed services and federal government’s critical defense goals – released survey results today revealing that traditional counter-drone technologies, such as jamming-based and kinetic solutions, are viewed as inadequate.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Talman Ranks No. 81 on Inc. Magazine’s List of the Midwest’s Fastest Growing Private Companies
March 16, 2021 GMT
CHICAGO, March 16, 2021 /PRNewswire/ With a revenue growth of 176 percent, Talman Consultants, LLC, today announced it ranks No. 81 on Inc. Magazine’s 2021 5000 Regionals: Midwest list, the most prestigious ranking of the fastest growing companies in Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin. This regional list represents a unique look at the most successful companies within the Midwest economy’s independent small businesses.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Merck Receives Priority Review From FDA for New Drug Application for HIF-2α Inhibitor Belzutifan (MK-6482)
March 16, 2021 GMT
KENILWORTH, N.J. (BUSINESS WIRE) Mar 16, 2021
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a New Drug Application (NDA) for the hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor belzutifan (pronounced bell-ZOO-ti-fan), a novel investigational candidate in Merck’s oncology pipeline, for the potential treatment of patients with von Hippel-Lindau (VHL) disease-associated renal cell carcinoma (RCC), not requiring immediate surgery. This NDA is based on data from the Phase 2 Study-004 trial, in which belzutifan showed a confirmed overall response rate of 36.1% (n=22/61) (95% CI: 24.2-49.4) in patients with VHL disease-associated